Albireo Pharma, Inc. (ALBO) Social Stream
ALBIREO PHARMA INC (ALBO) Price Targets From Analysts
Use the tables below to see what analysts covering ALBIREO PHARMA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $84 | $67 | $76.5 | $44.15 | 73.27% |
| 2022-02-23 | 5 | $84 | $67 | $75.8 | $44.15 | 71.69% |
| 2022-03-04 | 5 | $84 | $67 | $74.2 | $44.15 | 68.06% |
| 2022-04-13 | 5 | $80 | $68 | $73.75 | $44.15 | 67.04% |
| 2022-05-16 | 5 | $80 | $66 | $72.25 | $44.15 | 63.65% |
| 2022-05-18 | 5 | $80 | $66 | $71.5 | $44.15 | 61.95% |
| 2022-07-21 | 5 | $80 | $66 | $70.4 | $44.15 | 59.46% |
| 2022-08-16 | 6 | $72 | $40 | $56.8 | $44.15 | 28.65% |
| 2022-08-17 | 6 | $68 | $40 | $54.6 | $44.15 | 23.67% |
| 2022-09-08 | 7 | $68 | $40 | $54.666 | $44.15 | 23.82% |
| 2022-09-23 | 7 | $68 | $43 | $55.166 | $44.15 | 24.95% |
| 2022-09-27 | 7 | $68 | $43 | $53.666 | $44.15 | 21.55% |
| 2022-10-12 | 7 | $68 | $50 | $55.666 | $44.15 | 26.08% |
| 2022-10-13 | 7 | $68 | $50 | $58.333 | $44.15 | 32.12% |
| 2022-11-09 | 7 | $68 | $49 | $58.166 | $44.15 | 31.75% |
| 2022-11-10 | 7 | $68 | $49 | $58 | $44.15 | 31.37% |
| 2023-01-09 | 7 | $68 | $42 | $56.166 | $44.15 | 27.22% |
| 2023-01-11 | 7 | $55 | $42 | $47.333 | $44.15 | 7.21% |
| 2023-02-27 | 7 | $55 | $42 | $47.333 | $44.15 | 7.21% |
The Trend in the Analyst Price Target
Over the past 51 weeks, ALBO's average price target has gone down $26.
ALBO reports an average of 158.45% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-13 | 5 | 80 | 68 | 73.750 | 37.29 | 97.77% |
| 2022-05-18 | 5 | 80 | 66 | 70.400 | 21.16 | 232.7% |
| 2022-09-23 | 7 | 68 | 43 | 55.166 | 18.73 | 194.53% |
| 2022-11-10 | 7 | 68 | 49 | 58.000 | 21.47 | 170.14% |
| 2023-01-09 | 7 | 68 | 42 | 56.166 | 43.85 | 28.09% |
ALBO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.43 | 2 | 0 | 5 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 44 weeks, ALBO's average broker recommendation rating worsened by 1.43.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALBO as an investment opportunity.
- In terms of how ALBIREO PHARMA INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1882.15% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ALBIREO PHARMA INC's variance in analysts' estimates is lower than -294.39% of them.
- ALBO has a higher upside potential (average analyst target price relative to current price) than 496.83% of Pharmaceutical Products stocks.
- ALBIREO PHARMA INC's number of analysts covering the stock is higher than 1468.56% of stocks in the small market cap category.
In the Pharmaceutical Products industry, HGEN, OMER, and MACK are the three stocks most similar to ALBIREO PHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ALBO using the data that counts. Try POWR Ratings for free.